Lumigan Shortage Update: What Patients Need to Know in 2026

Patients who depend on Lumigan (bimatoprost ophthalmic solution) to manage glaucoma or ocular hypertension sometimes struggle to fill their prescriptions. If you've recently been told your pharmacy doesn't have Lumigan in stock, you're not alone — and there are concrete reasons why, along with clear steps you can take.

Is There a Lumigan Shortage in 2026?

As of 2026, Lumigan (bimatoprost) is NOT on the FDA's official drug shortage list. The FDA maintains a public database of medications in active shortage, and bimatoprost is not among them. Generic bimatoprost is produced by multiple manufacturers, and the national supply chain is functional.

However, a "no official shortage" status does not mean every patient can walk into any pharmacy and pick up their prescription. Individual pharmacies run out of stock, distribution can be uneven, and insurance complications can make filling feel nearly impossible at times.

Why Do Patients Still Have Trouble Filling Lumigan?

Despite no official shortage, these real-world factors contribute to access difficulties:

Brand vs. generic mismatch. Lumigan 0.01% (brand) is stocked less frequently than generic bimatoprost 0.03%. If your prescription is brand-specific, you may face delays.

Low unit volume. Eye drops are sold in tiny bottles. Pharmacies stock a few units at a time, and a week of active demand can wipe out a shelf.

Insurance prior authorization requirements. Some commercial insurance plans require patients to first try and fail on latanoprost (the cheapest prostaglandin) before approving Lumigan. This adds significant wait time.

Specialty pharmacy routing. Some insurance plans route ophthalmic drugs through specialty pharmacies or mail order, which adds processing time of several days.

Supply variability by region. Distribution centers serve specific geographic regions. A disruption at one center can affect multiple pharmacies in a region simultaneously.

The History of Lumigan Availability

Lumigan has been on the U.S. market since 2001, when the FDA first approved bimatoprost ophthalmic solution. Over the years, its brand formulation changed from 0.03% to 0.01% to reduce side effects like redness and eyelash growth while maintaining efficacy. The 0.03% brand Lumigan was eventually discontinued, and today only the 0.01% brand remains, alongside generic 0.03% bimatoprost from multiple manufacturers.

Bimatoprost has never been on the FDA's sustained shortage list the way some other ophthalmic medications have. Availability has been relatively stable, with only episodic stocking gaps at the local pharmacy level.

What Should I Do If I Can't Fill My Lumigan Prescription?

Do not stop your drops. Stopping Lumigan without a replacement allows IOP to rise. Even a few missed days can cause pressure spikes.

Call your ophthalmologist. Explain that you cannot find Lumigan in stock. They can call in a temporary substitute (latanoprost is commonly used as a bridge) or provide samples.

Use medfinder. medfinder calls pharmacies near you to check actual stock and texts you the results, saving you hours of calling around.

Ask about generic bimatoprost 0.03%. This is more widely stocked than brand Lumigan. Confirm with your doctor if the concentration switch is appropriate.

Ask your pharmacy to order it. Most pharmacies can get a special order of Lumigan within 1–3 business days from their wholesale distributor.

Should I Be Worried About Future Lumigan Availability?

As of 2026, there are no signals that bimatoprost faces supply chain threats that would drive a sustained shortage. The drug is manufactured by multiple companies globally. The biggest risk for individual patients is not a national shortage but the everyday variability of local pharmacy inventory.

The best protection is simple: refill your prescription 5–7 days before you run out, keep your eye doctor's contact information handy, and know which alternatives are available to you.

For a full list of alternatives, see: Alternatives to Lumigan if you can't fill your prescription.